Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated 8 minutes ago
Fierce Biotech Layoff Tracker 2026: Takeda takes away 4.5K roles; Valneva reduces workforce
8 minutes ago
As always, if you know of layoffs occurring at a biotech, please...
Biopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?
19 minutes ago
With the FDA now rudderless following the revelation that commissioner Marty Makary...
Create Medicines fashions $122M fundraise for in vivo CAR-T dreams
about 2 hours ago
As the wave of in vivo CAR-T hype crests, Create Medicines is...
Biogen advances Alzheimer’s tau program despite midphase miss
about 3 hours ago
A phase 2 trial of Biogen and Ionis Pharmaceuticals’ tau-targeting candidate missed...
Regenxbio reaps pivotal win for Duchenne muscular dystrophy gene therapy
about 4 hours ago
Regenxbio’s gene therapy for Duchenne muscular dystrophy has smashed the primary endpoint...
Aptose, facing cash crunch, exits blood cancer pact after Hanmi buyout blocks development
about 4 hours ago
Aptose Biosciences has scrapped a deal for a blood cancer drug candidate...
Icon opens early-phase research unit in San Antonio, plus satellite clinics to grow trial capabilities
about 22 hours ago
Global contract research organization Icon has announced the opening of a new...
With $1B Novo deal and diabetes ambitions undimmed, Lexicon is in ‘good shape to go crazy’
1 day ago
Three weeks into taking on the role of Lexicon Pharmaceuticals CEO back...
Humacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant
1 day ago
Humacyte was riding high in December 2024 when it secured an FDA...
Fosun pays $60M for option on AriBio’s phase 3 Alzheimer’s asset
1 day ago
Fosun Pharma has paid $60 million for an option on AriBio’s late-phase...
Valneva to lay off up to 15% of workforce in face of ‘adverse trend‘ in travel vaccines
1 day ago
Valneva is planning to shrink its headcount by up to 15% as...
Medtronic to shutter Santa Rosa plant as it restructures cardio vascular unit
1 day ago
Medtronic will shutter its Santa Rosa facility that produces coronary stents and...